Dose-dependent effect of tamoxifen in tamoxifen-resistant breast cancer cells via stimulation by the ERK1/2 and AKT signaling pathways

By                  

Oncology Reports, Vol. 29, Iss. 4, 2013-01 ,pp. : 1563-1569

Spandidos Publications

Access to resources Recommend Favorite

Sorafenib and nilotinib resensitize tamoxifen resistant breast cancer cells to tamoxifen treatment via estrogen receptor α

By        

International Journal of Oncology, Vol. 45, Iss. 5, 2014-01 ,pp. : 2167-2175

Spandidos Publications

Access to resources Recommend Favorite

Activation of mitogenic pathways and sensitization to estrogen-induced apoptosis: two independent characteristics of tamoxifen-resistant breast cancer cells?

By Scherbakov Alexander   Lobanova Yulia   Shatskaya Valentina   Onopchenko Oksana   Gershtein Elena   Krasil’nikov Mikhail  

Breast Cancer Research and Treatment, Vol. 100, Iss. 1, 2006-11 ,pp. : 1-11

Springer Publishing Company

Access to resources Recommend Favorite

Advanced concepts in estrogen receptor biology and breast cancer endocrine resistance: implicated role of growth factor signaling and estrogen receptor coregulators

By Schiff Rachel   Massarweh Suleiman   Shou Jiang   Bharwani Lavina   Arpino Grazia   Rimawi Mothaffar   Osborne C.  

Cancer Chemotherapy and Pharmacology, Vol. 56, Iss. 1, 2005-11 ,pp. : 10-20

Springer Publishing Company

Access to resources Recommend Favorite

Treatment Options For Postmenopausal Women with Tamoxifen-Resistant Advanced Breast Cancer

By Cheung K-L.   Robertson J.F.R.  

American Journal of Cancer, Vol. 1, Iss. 4, 2002-01 ,pp. : 293-300

Adis International

Access to resources Recommend Favorite